COMPANY
Currax Pharmaceuticals
Currax Pharmaceuticals is listed on ClinicalTrials.gov as the lead sponsor of 6 studies; the most recently updated is “Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)” (Phase 4, active not recruiting), in Obesity. From public records Source · Oct 12, 2026